Zosano and Novo agree to make GLP-1 patches; Servier exercises option for MacroGenics antibody; Sanofi expands alliance with Regulus; Seattle Genetics earns milestone from Takeda; and Sarepta reports pulmonary data for eteplirsen.
written on 06.02.2014
BioNotebook Deals and Data: Zosano/Novo, MacroGenics/Servier, Regulus/Sanofi, Seattle Genetics/Takeda, Sarepta
